Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Fulminant viral hepatitis is a rapid and severe impairment of liver functions (acute liver failure) with hepatic encephalopathy developing less than 8 weeks after the onset of jaundice, secondary to viral hepatitis mainly due to HBV, but also to HAV.
No clinical trials have been registered for fulminant viral hepatitis.
9 publications have been identified in PubMed for fulminant viral hepatitis. Research spans Basic Science / Preclinical (56%), Review / Meta-Analysis (22%), and Case Report / Case Series (22%).
Gervais A (2026). [PMID: 41348319](https://pubmed.ncbi.nlm.nih.gov/41348319/). *J Exp Med*. [Basic Science / Preclinical]
Elaziz DA (2025). [PMID: 41334112](https://pubmed.ncbi.nlm.nih.gov/41334112/). *J Hum Immun*. [Case Report / Case Series]
Wohlleber D (2025). [PMID: 39793603](https://pubmed.ncbi.nlm.nih.gov/39793603/). *Z Gastroenterol*. [Review / Meta-Analysis]
Biełka A (2025). [PMID: 41307271](https://pubmed.ncbi.nlm.nih.gov/41307271/). *Kardiol Pol*. [Case Report / Case Series]
Misumi I (2025). [PMID: 40970716](https://pubmed.ncbi.nlm.nih.gov/40970716/). *J Virol*. [Basic Science / Preclinical]
Wang Q (2024). [PMID: 39159560](https://pubmed.ncbi.nlm.nih.gov/39159560/). *Int Immunopharmacol*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:32 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Unknown (2024). [PMID: 38884522](https://pubmed.ncbi.nlm.nih.gov/38884522/). *J Pineal Res*. [Basic Science / Preclinical]
Unknown (2024). [PMID: 38884528](https://pubmed.ncbi.nlm.nih.gov/38884528/). *J Pineal Res*. [Basic Science / Preclinical]
Miao LY (2024). [PMID: 39623583](https://pubmed.ncbi.nlm.nih.gov/39623583/). *Zhonghua Gan Zang Bing Za Zhi*. [Review / Meta-Analysis]
AI-curated news mentioning fulminant viral hepatitis
Updated Jul 30, 2026
A recent study published in PubMed details a case of fulminant emphysematous hepatitis linked to Clostridium perfringens infection, highlighting the severe intravascular hemolysis associated with this condition. This research contributes to the understanding of rare infectious diseases and their complications.
Recent research highlights the diagnostic and therapeutic challenges posed by autoimmune hepatitis that is unmasked by acute viral hepatitis. This study emphasizes the need for improved diagnostic strategies and treatment protocols in managing these overlapping conditions.
The CDC acknowledges World Hepatitis Day, highlighting global efforts to combat viral hepatitis. This statement reflects on both successes and ongoing challenges in prevention and control.